John G Ullman & Associates Inc Azenta, Inc. Transaction History

John G Ullman & Associates Inc

  • $649 Million
  • Q3 2024

A detailed history of John G Ullman & Associates Inc transactions in Azenta, Inc. stock. As of the latest transaction made, John G Ullman & Associates Inc holds 79,793 shares of AZTA stock, worth $3.65 Million. This represents 0.6% of its overall portfolio holdings.

Number of Shares
79,793
Previous 80,493 0.87%
Holding current value
$3.65 Million
Previous $4.24 Million 8.74%
% of portfolio
0.6%
Previous 0.67%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024
SELL
$45.84 - $62.29 $32,088 - $43,603
-700 Reduced 0.87%
79,793 $3.87 Million
Q2 2024

Aug 08, 2024
SELL
$50.27 - $59.04 $23,878 - $28,044
-475 Reduced 0.59%
80,493 $4.24 Million
Q1 2024

May 06, 2024
SELL
$57.82 - $67.51 $66,493 - $77,636
-1,150 Reduced 1.4%
80,968 $4.88 Million
Q4 2023

Jan 31, 2024
SELL
$44.02 - $66.3 $11,005 - $16,575
-250 Reduced 0.3%
82,118 $5.35 Million
Q3 2023

Nov 01, 2023
BUY
$44.08 - $57.76 $395,573 - $518,338
8,974 Added 12.23%
82,368 $4.13 Million
Q2 2023

Aug 21, 2023
BUY
$36.45 - $46.68 $1.17 Million - $1.49 Million
31,981 Added 77.22%
73,394 $3.43 Million
Q1 2023

May 05, 2023
BUY
$39.51 - $61.95 $49,387 - $77,437
1,250 Added 3.11%
41,413 $1.85 Million
Q4 2022

Feb 08, 2023
SELL
$38.6 - $62.07 $61,760 - $99,312
-1,600 Reduced 3.83%
40,163 $2.34 Million
Q3 2022

Oct 19, 2022
SELL
$42.86 - $77.02 $4,286 - $7,702
-100 Reduced 0.24%
41,763 $1.79 Million
Q1 2022

Apr 29, 2022
SELL
$76.3 - $103.81 $17,472 - $23,772
-229 Reduced 0.54%
41,863 $3.47 Million
Q4 2021

Jan 26, 2022
SELL
$92.98 - $124.15 $4,741 - $6,331
-51 Reduced 0.12%
42,092 $4.34 Million
Q3 2021

Nov 02, 2021
SELL
$77.49 - $109.17 $23,247 - $32,751
-300 Reduced 0.71%
42,143 $4.31 Million
Q2 2021

Jul 23, 2021
SELL
$86.59 - $107.47 $25,977 - $32,241
-300 Reduced 0.7%
42,443 $4.04 Million
Q1 2021

Apr 22, 2021
SELL
$66.32 - $90.93 $754,389 - $1.03 Million
-11,375 Reduced 21.02%
42,743 $3.49 Million
Q4 2020

Feb 05, 2021
SELL
$46.7 - $75.22 $775,220 - $1.25 Million
-16,600 Reduced 23.47%
54,118 $3.67 Million
Q3 2020

Nov 06, 2020
SELL
$42.77 - $56.69 $937,518 - $1.24 Million
-21,920 Reduced 23.66%
70,718 $3.27 Million
Q2 2020

Jul 29, 2020
SELL
$26.54 - $44.24 $11,943 - $19,908
-450 Reduced 0.48%
92,638 $4.1 Million
Q1 2020

Apr 14, 2020
SELL
$22.69 - $44.14 $18,152 - $35,312
-800 Reduced 0.85%
93,088 $2.84 Million
Q4 2019

Jan 29, 2020
SELL
$35.49 - $48.05 $1.43 Million - $1.94 Million
-40,300 Reduced 30.03%
93,888 $3.94 Million
Q3 2019

Oct 21, 2019
SELL
$30.18 - $41.75 $276,358 - $382,304
-9,157 Reduced 6.39%
134,188 $4.97 Million
Q2 2019

Aug 02, 2019
SELL
$29.53 - $41.1 $79,731 - $110,970
-2,700 Reduced 1.85%
143,345 $5.56 Million
Q1 2019

Apr 30, 2019
SELL
$24.38 - $33.75 $21,332 - $29,531
-875 Reduced 0.6%
146,045 $4.28 Million
Q4 2018

Jan 29, 2019
SELL
$23.22 - $35.29 $32,856 - $49,935
-1,415 Reduced 0.95%
146,920 $3.85 Million
Q3 2018

Nov 02, 2018
SELL
$28.71 - $39.6 $2.2 Million - $3.04 Million
-76,801 Reduced 34.11%
148,335 $5.2 Million
Q2 2018

Jul 23, 2018
SELL
$24.88 - $36.36 $44,609 - $65,193
-1,793 Reduced 0.79%
225,136 $7.34 Million
Q1 2018

Apr 19, 2018
SELL
$23.3 - $30.15 $33,295 - $43,084
-1,429 Reduced 0.63%
226,929 $6.15 Million
Q4 2017

Jan 31, 2018
SELL
$22.54 - $34.39 $796,541 - $1.22 Million
-35,339 Reduced 13.4%
228,358 $5.45 Million
Q3 2017

Nov 03, 2017
BUY
$22.6 - $30.36 $5.96 Million - $8.01 Million
263,697
263,697 $8.01 Million

Others Institutions Holding AZTA

# of Institutions
336
Shares Held
49.4M
Call Options Held
186K
Put Options Held
405K
View Full List

About Azenta, Inc.

AZTA Quotes by TradingView
  • Ticker AZTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 75,020,400
  • Market Cap $3.43B
  • Description
  • Azenta, Inc. provides life science sample exploration and management solutions for the life sciences market in North America, Europe, China, the Asia Pacific, and internationally. The company operates through two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold sampl...
More about AZTA
Track This Portfolio

Track John G Ullman & Associates Inc Portfolio

Follow John G Ullman & Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of John G Ullman & Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on John G Ullman & Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email